Brokerages expect HCA Healthcare Inc (NYSE:HCA) to report earnings of $1.93 per share for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for HCA Healthcare’s earnings. The lowest EPS estimate is $1.83 and the highest is $2.09. HCA Healthcare posted earnings of $1.21 per share in the same quarter last year, which would indicate a positive year over year growth rate of 59.5%. The firm is expected to issue its next quarterly earnings results before the market opens on Tuesday, October 30th.
On average, analysts expect that HCA Healthcare will report full year earnings of $9.23 per share for the current fiscal year, with EPS estimates ranging from $9.07 to $9.32. For the next year, analysts expect that the company will report earnings of $9.98 per share, with EPS estimates ranging from $9.39 to $10.66. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that cover HCA Healthcare.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, topping the Zacks’ consensus estimate of $2.16 by $0.13. The firm had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.73 EPS.
A number of brokerages have recently commented on HCA. JPMorgan Chase & Co. increased their price target on shares of HCA Healthcare to $151.00 and gave the stock an “overweight” rating in a report on Monday, July 30th. SunTrust Banks increased their price target on shares of HCA Healthcare to $150.00 and gave the stock a “positive” rating in a report on Tuesday, September 4th. Mizuho reissued a “buy” rating and issued a $145.00 price target on shares of HCA Healthcare in a report on Thursday, August 2nd. Leerink Swann increased their price target on shares of HCA Healthcare from $125.00 to $140.00 and gave the stock an “outperform” rating in a report on Thursday, July 26th. Finally, Argus increased their price target on shares of HCA Healthcare to $150.00 and gave the stock a “buy” rating in a report on Friday, September 7th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $135.19.
In other HCA Healthcare news, insider Charles J. Hall sold 34,125 shares of the firm’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $129.93, for a total value of $4,433,861.25. Following the sale, the insider now owns 98,124 shares of the company’s stock, valued at approximately $12,749,251.32. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 1,689 shares of the firm’s stock in a transaction on Wednesday, July 25th. The stock was sold at an average price of $112.53, for a total transaction of $190,063.17. Following the completion of the sale, the senior vice president now directly owns 10,057 shares in the company, valued at approximately $1,131,714.21. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 170,257 shares of company stock worth $21,118,053. 2.80% of the stock is owned by insiders.
A number of institutional investors have recently made changes to their positions in the business. FMR LLC grew its holdings in HCA Healthcare by 54.9% in the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after acquiring an additional 1,944,961 shares during the last quarter. LSV Asset Management grew its holdings in HCA Healthcare by 9.2% in the 2nd quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after acquiring an additional 457,752 shares during the last quarter. Northern Trust Corp grew its holdings in HCA Healthcare by 4.2% in the 2nd quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock worth $355,023,000 after acquiring an additional 138,135 shares during the last quarter. Millennium Management LLC grew its holdings in HCA Healthcare by 32.3% in the 2nd quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock worth $174,270,000 after acquiring an additional 414,877 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in HCA Healthcare by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,222,343 shares of the company’s stock worth $125,413,000 after acquiring an additional 64,426 shares during the last quarter. 70.40% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE:HCA traded up $2.78 during trading on Tuesday, reaching $135.54. The company had a trading volume of 64,554 shares, compared to its average volume of 1,906,505. The firm has a market capitalization of $48.14 billion, a price-to-earnings ratio of 20.56, a PEG ratio of 1.23 and a beta of 0.49. HCA Healthcare has a 12 month low of $74.25 and a 12 month high of $141.11. The company has a debt-to-equity ratio of -7.64, a current ratio of 1.36 and a quick ratio of 1.15.
The firm also recently announced a quarterly dividend, which was paid on Friday, September 28th. Investors of record on Tuesday, September 4th were issued a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a dividend yield of 1.03%. The ex-dividend date was Friday, August 31st. HCA Healthcare’s dividend payout ratio is currently 21.24%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: Call Option
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.